WallStreetZenWallStreetZen

NYSE: NUS
Nu Skin Enterprises Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NUS stock forecasts and price targets.

Forecast return on equity

Is NUS forecast to generate an efficient return?

Company
11.96%
Industry
240.45%
Market
130.24%
NUS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NUS forecast to generate an efficient return on assets?

Company
5.79%
Industry
13.65%
NUS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NUS earnings per share forecast

What is NUS's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$1.01
Avg 2 year Forecast
$1.33

NUS revenue forecast

What is NUS's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$1.4B+4.71%
Avg 2 year Forecast
$1.5B+12.34%
NUS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NUS revenue growth forecast

How is NUS forecast to perform vs Household & Personal Products companies and vs the US market?

Company
4.71%
Industry
5.61%
Market
21.28%
NUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NUS vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
NUS$4.79N/AN/A
ACU$61.06N/AN/A
YSG$2.96N/AN/A
SKIN$0.60$1.30+118.49%Buy
SLSN$0.94N/AN/A
View Top Household & Personal Product Stocks

Nu Skin Enterprises Stock Forecast FAQ

What is NUS's earnings growth forecast for 2026-2027?

(NYSE: NUS) Nu Skin Enterprises's forecast annual earnings growth rate of N/A is not forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 54.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,098.01%.

Nu Skin Enterprises's earnings in 2026 is -$216,392,000.On average, 2 Wall Street analysts forecast NUS's earnings for 2026 to be $49,163,400, with the lowest NUS earnings forecast at $47,703,101, and the highest NUS earnings forecast at $51,110,466.

In 2027, NUS is forecast to generate $64,895,688 in earnings, with the lowest earnings forecast at $62,968,094 and the highest earnings forecast at $67,465,815.

If you're new to stock investing, here's how to buy Nu Skin Enterprises stock.

What is NUS's revenue growth forecast for 2026-2027?

(NYSE: NUS) Nu Skin Enterprises's forecast annual revenue growth rate of 4.71% is not forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 21.28%.

Nu Skin Enterprises's revenue in 2026 is $1,375,251,000.On average, 2 Wall Street analysts forecast NUS's revenue for 2026 to be $70,094,352,960, with the lowest NUS revenue forecast at $68,001,257,698, and the highest NUS revenue forecast at $72,868,921,098.

In 2027, NUS is forecast to generate $75,205,399,530 in revenue, with the lowest revenue forecast at $72,966,274,366 and the highest revenue forecast at $78,174,674,204.

What is NUS's forecast return on assets (ROA) for 2026-2027?

(NYSE: NUS) forecast ROA is 5.79%, which is lower than the forecast US Household & Personal Products industry average of 13.65%.

What is NUS's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: NUS) Nu Skin Enterprises's current Earnings Per Share (EPS) is -$4.44. On average, analysts forecast that NUS's EPS will be $1.01 for 2026, with the lowest EPS forecast at $0.98, and the highest EPS forecast at $1.05. In 2027, NUS's EPS is forecast to hit $1.33 (min: $1.29, max: $1.39).

What is NUS's forecast return on equity (ROE) for 2026-2027?

(NYSE: NUS) forecast ROE is 11.96%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.